{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Early+Parkinson+Disease+%28Early+PD%29", "query": { "condition": "Early Parkinson Disease (Early PD)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Early+Parkinson+Disease+%28Early+PD%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T08:10:20.350Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01060878", "title": "Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "PYM50028", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phytopharm", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "35 Years to 75 Years" }, "enrollment_count": 425, "start_date": "2010-11", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2013-03-04", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 41, "location_summary": "Scottsdale, Arizona • Irvine, California • La Jolla, California + 37 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01060878" }, { "nct_id": "NCT00601523", "title": "Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pramipexole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 511, "start_date": "2008-01", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 10, "location_summary": "Sun City, Arizona • Tempe, Arizona • La Jolla, California + 7 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Danbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00601523" }, { "nct_id": "NCT04658186", "title": "A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Early-stage Parkinson's Disease" ], "interventions": [ { "name": "UCB0599", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 496, "start_date": "2020-12-30", "completion_date": "2024-09-06", "has_results": true, "last_update_posted_date": "2025-10-31", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04658186" }, { "nct_id": "NCT00402233", "title": "A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Pramipexole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "31 Years", "maximum_age": null, "sex": "ALL", "summary": "31 Years and older" }, "enrollment_count": 312, "start_date": "2006-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-16", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 39, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Fountain Valley, California + 32 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00402233" }, { "nct_id": "NCT02642393", "title": "Study of Urate Elevation in Parkinson's Disease, Phase 3", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "Inosine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Michael Alan Schwarzschild", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 298, "start_date": "2016-06", "completion_date": "2019-06", "has_results": true, "last_update_posted_date": "2020-07-28", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02642393" }, { "nct_id": "NCT04201093", "title": "Fixed-Dose Trial in Early Parkinson's Disease (PD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Tavapadon", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 529, "start_date": "2019-12-13", "completion_date": "2024-06-28", "has_results": true, "last_update_posted_date": "2025-07-28", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Fountain Valley, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04201093" }, { "nct_id": "NCT05308238", "title": "Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Occupational therapy intervention group", "type": "BEHAVIORAL" }, { "name": "Disease management education group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "San Jose State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 50, "start_date": "2022-04-18", "completion_date": "2024-03-13", "has_results": false, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 2, "location_summary": "San Jose, California • New York, New York", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05308238" }, { "nct_id": "NCT07214974", "title": "Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Mild Cognitive Impairment (MCI)", "Early Stages of Cognitive Decline", "Alzheimer's Disease Dementia", "Alzheimer's Disease Diagnosis", "Alzheimer's Disease and Related Dementias", "Parkinson's Disease", "Parkinson's Disease (PD)", "Parkinson's Disease With Wearing-off Motor Fluctuations", "Dementia (Diagnosis)", "Dementia MCI (Mild Cognitive Impairment)" ], "interventions": [ { "name": "Structured wellness care", "type": "BEHAVIORAL" }, { "name": "Wearable brain-computer interface devices", "type": "DEVICE" }, { "name": "Stem Cell Therapy - Experimental", "type": "BIOLOGICAL" }, { "name": "Control - Placebo Comparator", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE", "BIOLOGICAL", "OTHER" ], "sponsor": "Noah Tech, Corp.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 600, "start_date": "2026-09-01", "completion_date": "2030-01-03", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 1, "location_summary": "Palisades Park, New Jersey", "locations": [ { "city": "Palisades Park", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07214974" }, { "nct_id": "NCT00291265", "title": "Measures of Motor Impairment in Early Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 10, "start_date": "2006-02-09", "completion_date": "2010-02-02", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00291265" }, { "nct_id": "NCT02579473", "title": "A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "SER-214", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Serina Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2016-01", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2023-04-11", "last_synced_at": "2026-06-10T08:10:20.350Z", "location_count": 4, "location_summary": "Birmingham, Alabama • Hallandale, Florida • Augusta, Georgia + 1 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hallandale", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02579473" } ] }